These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1433 related items for PubMed ID: 30362544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E, Jouve C, Hulot JS.
    Cardiovasc Res; 2020 Apr 01; 116(5):894-907. PubMed ID: 31584620
    [Abstract] [Full Text] [Related]

  • 4. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A, Azizian K, Parsian H, Rafieian S, Shafiei-Irannejad V, Kheyrollah M, Yousefi M, Majidinia M, Yousefi B.
    J Cell Physiol; 2019 Aug 01; 234(8):12267-12277. PubMed ID: 30697727
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
    Rasoulinejad SA, Maroufi F.
    Mol Biotechnol; 2021 Sep 01; 63(9):768-779. PubMed ID: 34057656
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Conditional Control of CRISPR/Cas9 Function.
    Zhou W, Deiters A.
    Angew Chem Int Ed Engl; 2016 Apr 25; 55(18):5394-9. PubMed ID: 26996256
    [Abstract] [Full Text] [Related]

  • 13. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T, Nihongaki Y, Sato M.
    Methods Mol Biol; 2021 Apr 25; 2312():225-233. PubMed ID: 34228293
    [Abstract] [Full Text] [Related]

  • 14. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A, Mahfouz MM.
    Exp Mol Med; 2016 Oct 14; 48(10):e265. PubMed ID: 27741224
    [Abstract] [Full Text] [Related]

  • 15. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV, Lavrov AV.
    Mol Biol (Mosk); 2017 Oct 14; 51(4):582-594. PubMed ID: 28900076
    [Abstract] [Full Text] [Related]

  • 16. CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.
    Sharma G, Sharma AR, Bhattacharya M, Lee SS, Chakraborty C.
    Mol Ther; 2021 Feb 03; 29(2):571-586. PubMed ID: 33238136
    [Abstract] [Full Text] [Related]

  • 17. Precision genome editing in the CRISPR era.
    Salsman J, Dellaire G.
    Biochem Cell Biol; 2017 Apr 03; 95(2):187-201. PubMed ID: 28177771
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
    Cullot G, Boutin J, Toutain J, Prat F, Pennamen P, Rooryck C, Teichmann M, Rousseau E, Lamrissi-Garcia I, Guyonnet-Duperat V, Bibeyran A, Lalanne M, Prouzet-Mauléon V, Turcq B, Ged C, Blouin JM, Richard E, Dabernat S, Moreau-Gaudry F, Bedel A.
    Nat Commun; 2019 Mar 08; 10(1):1136. PubMed ID: 30850590
    [Abstract] [Full Text] [Related]

  • 20. Application of the CRISPR/Cas system for genome editing in microalgae.
    Zhang YT, Jiang JY, Shi TQ, Sun XM, Zhao QY, Huang H, Ren LJ.
    Appl Microbiol Biotechnol; 2019 Apr 08; 103(8):3239-3248. PubMed ID: 30877356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.